BiochemistryACS Infectious DiseasesPeer-reviewed
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Catherine N. Russell, Jennifer Levin Carter, Juliet M. Borgia…·Nathaniel G. Jones
This paper identifies LdBDF5 as a potential drug target for antileishmanial therapy by showing its interaction with human bromodomain inhibitors and demonstrating antipromastigote activity of SGC-CBP30.
14 citations